Thermo Fisher Scientific (TMO) Tops Q2 EPS by 25c; Raises guidance

Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $5.37, $0.25 better than the analyst estimate of $5.12. Revenue for the quarter came in at $10.54 billion versus the consensus estimate of $10.5 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2024 EPS of $21.29-$22.07, versus the consensus of $21.70. Thermo Fisher Scientific sees FY2024 revenue of $42.4-43.3 billion, versus the consensus of $42.96 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• Hindustan Unilever Ltd (HUVR:IN) PT Lowered to INR2,440 at HSBC
• BofA Securities Reiterates Buy Rating on UltraTech Cement Ltd (UTCEM:IN)